Cargando…

Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis

AIM: Prophylactic human papillomavirus (HPV) vaccines are highly effective at preventing pre–cancerous cervical lesions when given in a three–dose schedule. Some post–hoc trial data suggest that one dose prevents HPV infection. If one dose could prevent pre–cancerous cervical lesions, then global ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brotherton, Julia ML., Budd, Alison, Rompotis, Christopher, Bartlett, Natasha, Malloy, Michael J., Andersen, Rachael L., Coulter, Kim AR., Couvee, Peter W., Steel, Nerida, Ward, Gail H., Saville, Marion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658930/ https://www.ncbi.nlm.nih.gov/pubmed/31319173 http://dx.doi.org/10.1016/j.pvr.2019.100177

Ejemplares similares

Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia
por: Brotherton, Julia M.L., et al.
Publicado: (2015)

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
por: Gertig, Dorota M, et al.
Publicado: (2013)

Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient?
por: Smith, Megan A., et al.
Publicado: (2021)

Implementation of Australia’s renewed cervical screening program: Preparedness of general practitioners and nurses
por: Sultana, Farhana, et al.
Publicado: (2020)

Mobile phones are a viable option for surveying young Australian women: a comparison of two telephone survey methods
por: Liu, Bette, et al.
Publicado: (2011)

Women’s experience with home-based self-sampling for human papillomavirus testing
por: Sultana, Farhana, et al.
Publicado: (2015)

The experience of under-screened and never-screened participants using clinician-supported self-collection cervical screening within the Australian National Cervical Screening Program
por: Creagh, Nicola S, et al.
Publicado: (2022)

Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus‐based cervical screening program: A cross‐sectional survey
por: Chadwick, Verity, et al.
Publicado: (2022)

The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
por: Patel, Cyra, et al.
Publicado: (2018)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Should Cervical Cancer Screening be Performed Before the Age of 25 Years?
por: Moscicki, Anna-Barbara, et al.
Publicado: (2018)

Structure and Grammaticalization of Serial Verb Constructions in Sign Language of the Netherlands—A Corpus-Based Study
por: Couvee, Sascha, et al.
Publicado: (2018)

Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia
por: Sultana, Farhana, et al.
Publicado: (2014)

Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program
por: Garland, Suzanne M, et al.
Publicado: (2011)

Rationalizing the HPV vaccination schedule: A long road to a worthwhile destination
por: Brotherton, Julia ML.
Publicado: (2019)

‘I’m a bit of a champion for it actually’: qualitative insights into practitioner-supported self-collection cervical screening among early adopting Victorian practitioners in Australia
por: Zammit, Claire, et al.
Publicado: (2023)

One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer
Publicado: (2022)

Costs of delivering human papillomavirus vaccination using a one- or two-dose strategy in Tanzania
por: Hsiao, Amber, et al.
Publicado: (2023)

Impact of HPV vaccination: Achievements and future challenges()
por: Brotherton, Julia M.L.
Publicado: (2019)

The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support
por: Keane, Adam, et al.
Publicado: (2021)

Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis
por: Prem, Kiesha, et al.
Publicado: (2023)

Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia
por: Canfell, Karen, et al.
Publicado: (2018)

Implementation of Australia’s primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study
por: Brotherton, Julia M.L., et al.
Publicado: (2023)

Self-Collection for Cervical Screening Programs: From Research to Reality
por: Hawkes, David, et al.
Publicado: (2020)

Understanding the participation of breast screening among women born in predominantly Muslim countries living in Victoria, Australia from record-linkage data
por: Yeasmeen, Tahira, et al.
Publicado: (2020)

Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)
por: Young, Elisa J, et al.
Publicado: (2013)

Uptake and acceptability of human papillomavirus self-sampling in rural and remote aboriginal communities: evaluation of a nurse-led community engagement model
por: Dutton, Tegan, et al.
Publicado: (2020)

Getting the timing right: Women’s views on the best time to announce changes to cancer screening policy recommendations
por: Dodd, Rachael H., et al.
Publicado: (2020)

Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use
por: Smith, Megan A., et al.
Publicado: (2016)

Oncogenic human papillomaviruses
por: McBride, Alison A.
Publicado: (2017)

Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening
por: Velentzis, Louiza S., et al.
Publicado: (2023)

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study
por: Smith, Megan A, et al.
Publicado: (2022)

Predicting Early Literacy: Auditory and Visual Speech Decoding in Deaf and Hard-of-Hearing Children
por: Couvee, Sascha, et al.
Publicado: (2022)

Predicting variation in word decoding development in deaf and hard-of-hearing children
por: Couvee, Sascha, et al.
Publicado: (2023)

Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
por: Mesher, David, et al.
Publicado: (2016)

Factors Associated with Human Papillomavirus Vaccination Among Diverse Adolescents in a Region with Low Human Papillomavirus Vaccination Rates
por: Kepka, Deanna, et al.
Publicado: (2018)

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial
por: Watson-Jones, Deborah, et al.
Publicado: (2022)

Public perspectives on acquired brain injury rehabilitation and components of care: A Citizens’ Jury
por: Lannin, Natasha A., et al.
Publicado: (2020)

The Papillomavirus Episteme: a major update to the papillomavirus sequence database
por: Van Doorslaer, Koenraad, et al.
Publicado: (2017)

Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India
por: M de Carvalho, Tiago, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cv177okocg8fcjaeadhgl21lf0